That's the big question, all the other clinical applications beyond SR-aGVHD. Unless we get the P3 results for CHF or CLBP in the next few weeks (and we could), we will have to wait and see if we get a clear cut first readout from the P3 COVID-19 / ARDS trial in early September.
It is bizarre how many media commentators are still going off the tracks, thinking this vote was about COVID-19. And no mention of the Phase 3 trial nearing completion, the the science that so many now say they want seems to be out of their fields of view.
MSB Trading 2020 - a new dawn, page-564
-
- There are more pages in this discussion • 12,507 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.5¢ |
Change
-0.020(2.12%) |
Mkt cap ! $1.056B | |||
| Open | High | Low | Value | Volume |
| 93.0¢ | 93.5¢ | 92.0¢ | $2.103M | 2.270M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 106422 | 92.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 93.0¢ | 59027 | 3 |
View Market Depth
| Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |